Portage Biotech Inc. logo

Portage Biotech Inc.

NASDAQ:PRTG

Overview | Financials
Company Name Portage Biotech Inc.
Symbol PRTG
Currency USD
Price 6.71
Market Cap 3,550,113
Dividend Yield 0%
52-week-range 2.1 - 47
Industry Biotechnology
Sector Healthcare
CEO Dr. Ian B. Walters M.B.A., M.D.
Website https://www.portagebiotech.com

An error occurred while fetching data.

About Portage Biotech Inc.

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule

Related Stocks

Vascular Biogenics Ltd. logo

Vascular Biogenics Ltd.

VBLT

0.156 USD

ChromaDex Corporation logo

ChromaDex Corporation

CDXC

3.44 USD

Omega Therapeutics, Inc. logo

Omega Therapeutics, Inc.

OMGA

1.04 USD

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

2.97 USD

Societal CDMO, Inc. logo

Societal CDMO, Inc.

SCTL

1.1 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

8.1 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

12.84 USD

Financials

Numbers are in millions USD

Numbers are in millions USD